SHORT MINI FUTURE WARRANT - MERCK & CO. Share Price

Certificat

DE000GG5FT71

Market Closed - BOERSE MUENCHEN 11:57:01 03/06/2024 pm IST
1.71 EUR -13.20% Intraday chart for SHORT MINI FUTURE WARRANT - MERCK & CO.
Current month-13.20%
1 month-1.16%
Date Price Change
03/24/03 1.71 -13.20%
31/24/31 1.97 +11.30%
30/24/30 1.77 -7.81%
29/24/29 1.92 +2.13%
28/24/28 1.88 +18.24%

Real-time BOERSE MUENCHEN

Last update June 03, 2024 at 11:57 pm IST

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying MERCK & CO., INC.
Issuer Goldman Sachs
WKN GG5FT7
ISINDE000GG5FT71
Date issued 19/03/2024
Strike 146.5 $
Maturity Unlimited
Parity 10 : 1
Emission price 2.27
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.26
Lowest since issue 1.27

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
128.4 USD
Average target price
141.9 USD
Spread / Average Target
+10.48%
Consensus